Edition:
United States

Corvus Pharmaceuticals Inc (CRVS.A)

CRVS.A on American Stock Exchange

3.90USD
16 May 2019
Change (% chg)

-- (--)
Prev Close
$3.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
107
52-wk High
$13.74
52-wk Low
$3.24

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: --
Market Cap(Mil.): $118.19
Shares Outstanding(Mil.): 29.33
Dividend: --
Yield (%): --

Financials

  CRVS.A Industry Sector
P/E (TTM): -- 93.20 35.48
EPS (TTM): -1.52 -- --
ROI: -36.63 7.47 11.75
ROE: -37.22 7.94 16.52

Earnings vs. Estimates